The Implementation of Rifapentine and Isoniazid (3HP) in two Remote Arctic Communities with a Predominantly Inuit Population, the Taima TB 3HP Study

Study of 247 participants in Nunavut examines the feasibility and safety profile of 3HP for the treatment of Latent Tuberculosis Infection (LTBI).
Author/Creator
G. G. Alvarez
D. Van Dyk
R. Mallick
S. Lesperance
P. Demaio ... [et al.]
Open Access
Yes
Primary Source
No
Citation
International Journal of Circumpolar Health, vol. 79, no. 1, Article: 1758501, May 7, 2020
Publication Date
2020-05-07
Subjects
Inuit » Communities
Health & Well-Being » Substance Use, Abuse & Treatment
Health & Well-Being » Infectious Diseases » Tuberculosis
Health & Well-Being » Health Care Practices
Location
Canada
Canada » Nunavut » Iqaluit
Canada » Nunavut » Qikiqtarjuaq
First Nation, Metis, Inuit Locations
Iqaluit
Qikiqtarjuaq
Resource Type
Articles -- Scholarly, peer reviewed
Format
Text -- PDF
Text -- HTML
Language
English
Login or Register to create bookmarks.

Export Record

RIS
EndNote
CSV